Custom Peptide Synthesis: A Step-by-Step Guide from Sequence to Delivered Product

Custom peptide synthesis has become routine in discovery research, but the outcome of a project is largely decided by choices made before the first coupling. This guide follows a typical project from sequence to delivered product and explains what happens at each stage, so researchers can write better specifications and ask better questions. Peptides described here are research materials supplied for laboratory use only; they are not intended for human or veterinary use, and no part of this guide is medical or dosing advice.

Step 1: Sequence Feasibility Review

Every order should begin with a chemist's review, not an instant price. The reviewer considers length — standard solid-phase synthesis is routinely reliable up to roughly 30-50 residues, while longer sequences call for fragment strategies — along with hydrophobic content, charge distribution, and residues that complicate synthesis or handling, such as cysteine, methionine, and tryptophan. Aggregation-prone motifs, including long runs of hydrophobic or beta-sheet-forming residues, are flagged early because they affect both synthesis and purification. A good manufacturer returns a strategy and an honest risk assessment with the quote, and asks clarifying questions before money changes hands.

Step 2: Solid-Phase Peptide Synthesis

Nearly all custom peptides are made by solid-phase peptide synthesis (SPPS). The C-terminal residue is anchored to an insoluble resin, and the chain is extended residue by residue from the C-terminus toward the N-terminus. Excess reagents are simply washed away, which makes the cycle repetitive and automatable.

The dominant chemistry is Fmoc/tBu: the alpha-amino group is protected with base-labile Fmoc, removed each cycle with piperidine, while side chains carry acid-labile protecting groups. The older t-Boc/benzyl chemistry uses acid-labile main-chain protection and is still chosen for some specialty applications. Each cycle consists of deprotection, washing, activation, and coupling — typically with reagents such as HBTU, HATU, or DIC plus an additive — followed by capping of any chains that failed to couple, so they cannot generate deletion sequences later. At the end, the completed peptide is cleaved from the resin with a TFA cocktail containing scavengers, and the crude peptide is precipitated from cold ether.

Step 3: Handling Difficult Sequences

Some sequences resist routine synthesis. Hydrophobic stretches couple poorly and can aggregate on the resin; sterically hindered residues such as valine and isoleucine slow coupling; proline-rich and repetitive sequences, including poly-alanine and poly-glutamine, are prone to incomplete reaction; and amyloidogenic sequences can fold into beta-sheet aggregates mid-synthesis. Experienced manufacturers counter these problems with double or triple coupling, elevated temperature or microwave heating, pseudoproline dipeptides that interrupt aggregation, Dmb/Hmb backbone protection, lower resin loading, and solvent additives. For long or very difficult peptides, fragment condensation or ligation strategies may be proposed. A supplier who describes these options is treating your peptide as a chemistry problem, which is what you want.

Step 4: Modifications and Conjugates

Most research peptides carry at least one modification. Common examples include:

• N-terminal acetylation, which removes the positive charge and mimics a protein N-terminus.
• C-terminal amidation, required for the biological activity of many peptide hormones.
• Cyclization: head-to-tail, disulfide bridging, lactam formation, or stapling, used to constrain conformation and improve stability.
• D-amino acids and non-natural amino acids for stability and structure-activity studies.
• Phosphorylation or sulfation for signaling work.
• PEGylation to improve solubility and in-assay behavior.
• Biotinylation for capture and detection assays.
• Fluorescent labels such as FITC, FAM, TAMRA, and Cy dyes.
• Palmitoylation and multiple antigen peptide (MAP) constructs.

Each modification changes purification and QC: dyes alter retention time and mass, disulfides require a defined oxidation strategy, and PEG introduces polydispersity. Specify modifications in the first inquiry so the feasibility review covers the actual target molecule rather than an idealized sequence.

Step 5: Purification by Preparative HPLC

After cleavage, crude purity typically declines as length increases. Purification uses preparative RP-HPLC under conditions that mirror the analytical method, and fractions are pooled and re-analyzed to confirm the final purity. Suppliers offer defined purity tiers — commonly crude, >70%, >75%, >80%, >85%, >90%, >95%, and >98% — and the right tier balances assay requirements against cost. When the TFA counter-ion would interfere with cell work, an ion-exchange or desalting step converts the peptide to the acetate salt.

Step 6: Lyophilization and Quality Control

The purified solution is freeze-dried to a stable powder. Residual water is measured by Karl Fischer titration, and each batch is released against a QC panel: HPLC purity, mass spectrometry for identity, peptide content, counter-ion, and water content, with endotoxin testing available on request for cell-culture applications. Oxidation-sensitive peptides are packaged under inert atmosphere in amber vials. QC data is archived by lot number and accompanies the shipment.

Scale, Cost, and Turnaround

Research orders span milligrams to tens of grams, and manufacturers can scale to kilogram quantities when a lead advances. Cost is driven by length, purity tier, difficulty, modifications, and quantity, so a 25-residue peptide at >95% purity will cost more per milligram than the same sequence at >70%. Standard turnaround is commonly two to four weeks depending on queue and complexity, with rush options and longer timelines for difficult sequences, large scale, or regulated-quality batches.

What to Include in a Quote Request

A complete inquiry produces an accurate quote on the first pass:

• Sequence in one-letter code, with the N- and C-terminal states stated (free versus acetyl/amide).
• Quantity in milligrams or grams.
• Target purity tier.
• Modifications and any special QC requirements.
• Preferred salt form (TFA or acetate).
• Deadline and delivery destination.

How Shandong Shengyuan Runs This Workflow

Shandong Shengyuan Peptide Technology Co., Ltd. is a peptide manufacturer based in Shandong, China. Its workflow follows the sequence above: feasibility review and quotation, synthesis, preparative HPLC purification, QC release with a COA and analytical data, lyophilization, and packaging for shipment, with communication at key milestones. Technical staff can advise on feasibility, modifications, and the purity tier appropriate to your assay. Products remain research materials for laboratory use only, never for human or veterinary use.